YER189W Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YER189WUncharacterized protein YER189W antibody
Target Names
YER189W
Uniprot No.

Q&A

What is YER189W and why is it studied?

YER189W is a gene in Saccharomyces cerevisiae (budding yeast) that encodes a protein of significant research interest. Similar to other yeast proteins such as YER067W (also known as RGI1), YER189W may be involved in stress responses and cellular metabolism pathways. YER067W, for instance, is associated with energy metabolism and is strongly induced in response to various stress conditions, including temperature changes, osmotic stress, and unfolded protein responses . By extension, YER189W may have related functions worth investigating through antibody-based detection methods.

How are antibodies against YER189W typically generated?

Antibodies against YER189W are typically generated through immunization protocols using purified recombinant YER189W proteins. The production process generally follows these steps:

  • Expression of the YER189W gene in appropriate host systems (bacterial, yeast, mammalian, or insect cells)

  • Purification of the expressed protein

  • Immunization of host animals (typically rabbits or mice) with the purified protein

  • Collection and purification of antibodies from host serum

  • Validation of antibody specificity through appropriate controls

Recombinant protein technology allows for precise control over modifications, production scale, and synthesis tailored to experimental needs .

What are the common applications of YER189W antibodies in yeast research?

YER189W antibodies serve multiple research purposes:

  • Protein localization studies using immunofluorescence microscopy (similar to techniques used for YER067W, which was found to be associated with cellular membranes)

  • Protein expression analysis under various stress conditions

  • Protein-protein interaction studies via co-immunoprecipitation

  • Chromatin immunoprecipitation (ChIP) if YER189W has DNA-binding properties

  • Western blot analysis for protein expression quantification

These applications help researchers understand the functional role of YER189W in yeast cellular processes.

How can YER189W antibodies be validated for specificity in complex yeast extracts?

Validating YER189W antibodies requires a multi-faceted approach:

Validation MethodExperimental ApproachExpected OutcomePotential Pitfalls
Genetic validationCompare wild-type vs. YER189W deletion strainsSignal present in wild-type, absent in deletionBackground signals may persist
Peptide competitionPre-incubate antibody with purified YER189W proteinReduced or eliminated signalIncomplete blocking
Cross-reactivity testingTest against related yeast proteinsNo signal with homologous proteinsCross-reactivity with structural homologs
Immunoprecipitation-Mass SpectrometryIP followed by MS identificationYER189W as predominant hitCo-precipitation of interacting proteins
Multiple antibody comparisonUse antibodies targeting different epitopesConsistent localization/detection patternsEpitope accessibility variation

A comprehensive validation approach increases confidence in the specificity of YER189W antibodies, particularly when working with complex yeast extracts containing thousands of proteins.

How do expression conditions affect epitope accessibility of YER189W for antibody recognition?

Expression conditions significantly impact epitope accessibility of YER189W for antibody recognition. Similar to observations with YER067W, YER189W expression may be regulated by various stress conditions . Researchers should consider:

  • Growth phase considerations: YER189W expression levels may vary between log phase and stationary phase

  • Stress-induced conformational changes: High temperature, osmotic stress, or nutrient limitation may alter protein conformation

  • Post-translational modifications: Phosphorylation, glycosylation, or other modifications may mask antibody epitopes

  • Protein-protein interactions: Binding partners may obscure antibody binding sites

  • Subcellular compartmentalization: Membrane association (as observed with YER067W) may affect antibody accessibility

Experimental designs should account for these variables when using YER189W antibodies for detection under different cellular conditions.

What are the challenges in using YER189W antibodies for co-immunoprecipitation studies?

Co-immunoprecipitation (Co-IP) with YER189W antibodies presents several technical challenges:

  • Preservation of protein interactions: Lysis conditions must be optimized to maintain native interactions while efficiently extracting YER189W

  • Antibody orientation: Immobilization strategy affects antigen accessibility and interaction preservation

  • Cross-linking considerations: Chemical cross-linking may stabilize transient interactions but introduce artifacts

  • Negative controls: YER189W deletion strains provide the most stringent control for antibody specificity

  • Washing stringency: Balance between removing non-specific interactions and preserving genuine partners

To address these challenges, researchers should perform preliminary experiments to optimize buffer conditions, antibody concentrations, and incubation parameters specifically for YER189W Co-IP studies.

What fixation and permeabilization protocols are optimal for immunofluorescence detection of YER189W?

Optimizing immunofluorescence protocols for YER189W detection requires careful consideration of fixation and permeabilization methods:

  • Formaldehyde fixation (4%, 15-30 minutes): Preserves protein localization while maintaining epitope accessibility

  • Methanol fixation (-20°C, 6 minutes): Alternative approach if formaldehyde masks epitopes

  • Spheroplasting with zymolyase: Critical for antibody penetration through yeast cell wall

  • Permeabilization with 0.1% Triton X-100: Facilitates antibody access to intracellular compartments

  • Blocking with 3% BSA: Reduces non-specific binding

If YER189W is membrane-associated like YER067W , detergent concentration and incubation time must be carefully optimized to preserve membrane structure while allowing antibody access. Comparison of multiple fixation protocols is recommended to determine optimal conditions for specific YER189W antibodies.

How should researchers troubleshoot inconsistent Western blot results with YER189W antibodies?

Inconsistent Western blot results with YER189W antibodies may stem from multiple sources:

  • Sample preparation issues:

    • Ensure complete protein extraction through optimized lysis buffers

    • Include protease inhibitors to prevent degradation

    • Standardize protein quantification methods

  • Transfer efficiency problems:

    • Optimize transfer conditions based on YER189W molecular weight

    • Consider semi-dry vs. wet transfer based on protein properties

    • Verify transfer efficiency with reversible staining

  • Antibody-specific factors:

    • Titrate antibody concentration to determine optimal dilution

    • Test extended incubation times at 4°C

    • Evaluate different blocking agents (BSA vs. milk)

  • Detection sensitivity:

    • Compare chemiluminescent, fluorescent, and chromogenic detection

    • Consider enhanced chemiluminescence for low-abundance detection

    • Evaluate signal amplification systems

  • Protein expression variability:

    • Account for changes in YER189W expression under different stress conditions, similar to the variable expression observed with YER067W

What approaches can researchers use to study protein-protein interactions involving YER189W?

Researchers can employ multiple complementary approaches to study YER189W protein interactions:

  • Affinity purification coupled with mass spectrometry (AP-MS):

    • Tag YER189W with epitope tags (FLAG, HA, etc.)

    • Purify complexes under native conditions

    • Identify interacting partners through mass spectrometry

  • Proximity-dependent biotin identification (BioID):

    • Fuse YER189W to a biotin ligase

    • Identify proximal proteins through streptavidin purification and MS analysis

    • Distinguishes transient from stable interactions

  • Yeast two-hybrid screening:

    • Use YER189W as bait to screen for interacting partners

    • Confirm interactions through reciprocal experiments

    • Validate with orthogonal methods

  • Fluorescence resonance energy transfer (FRET):

    • Tag YER189W and potential partners with fluorescent proteins

    • Measure energy transfer as indicator of proximity

    • Provides spatial information on interactions

  • Co-immunoprecipitation with YER189W antibodies:

    • Optimize extraction conditions to preserve interactions

    • Use crosslinking to stabilize transient interactions

    • Perform under varying physiological conditions

Each method has distinct advantages and limitations, warranting a multi-method approach for comprehensive interaction mapping.

How should researchers interpret changes in YER189W expression patterns under different stress conditions?

Interpreting YER189W expression changes requires contextual analysis similar to other stress-responsive yeast genes like YER067W :

  • Establish reliable baseline expression across growth phases

  • Compare expression changes across multiple stress conditions to identify patterns

  • Correlate expression changes with physiological responses

  • Consider post-transcriptional regulation that may affect protein levels

  • Evaluate expression in relation to known stress response pathways

Data interpretation should account for the observation that stress-responsive yeast genes often display coordinated expression patterns with functionally related genes . Clustering analysis comparing YER189W expression with genes of known function may provide insights into its biological role.

What controls are essential when using YER189W antibodies for chromatin immunoprecipitation experiments?

Chromatin immunoprecipitation (ChIP) experiments with YER189W antibodies require rigorous controls:

  • Input control: Provides baseline for normalization

  • No-antibody control: Assesses non-specific binding to beads

  • IgG control: Evaluates background immunoprecipitation

  • YER189W deletion strain: Confirms antibody specificity

  • Positive control regions: Known binding sites of transcription factors

  • Negative control regions: Genomic regions unlikely to be bound

  • Technical replicates: Ensures reproducibility

  • Biological replicates: Accounts for biological variation

Additionally, researchers should consider crosslinking optimization, sonication parameters, and washing stringency to maximize signal-to-noise ratio in YER189W ChIP experiments.

How can emerging antibody technologies enhance YER189W research?

Emerging technologies offer new opportunities for YER189W antibody research:

  • Single-domain antibodies (nanobodies):

    • Smaller size allows access to restricted epitopes

    • Enhanced stability for in vivo applications

    • Generated through camelid immunization or synthetic libraries

  • Recombinant antibody fragments:

    • Precisely defined binding regions

    • Reduced cross-reactivity

    • Potential for site-specific modifications

  • Antibody engineering approaches:

    • Epitope-focused design for improved specificity

    • Modular recognition domains for multifunctional applications

    • Stimulus-responsive antibody variants

  • Intrabodies for in vivo targeting:

    • Expression within cells for real-time monitoring

    • Direct manipulation of YER189W in living yeast

    • Potential for conditional inhibition studies

These technologies may overcome limitations of conventional antibodies, particularly for studying membrane-associated proteins like YER189W may be, based on similarities to YER067W .

What strategies can integrate YER189W antibody data with other -omics approaches?

Integrating YER189W antibody data with other -omics approaches provides comprehensive insights:

Omics ApproachIntegration StrategyResearch Insight
TranscriptomicsCorrelate protein levels with mRNA expressionPost-transcriptional regulation
ProteomicsCompare antibody-based quantification with MS-based approachesValidation of expression patterns
MetabolomicsLink YER189W abundance with metabolic changesFunctional impact on metabolism
InteractomicsCombine antibody-based interaction studies with global interactome dataNetwork context of interactions
PhenomicsCorrelate antibody-detected expression with phenotypic outcomesPhysiological significance

Integration strategies should consider the temporal dynamics of different molecular events and the potential for feed-forward and feedback regulation within cellular networks.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.